Pityriasis rosea-like eruption due to ergotamine: A case report [3]

Journal of Dermatology

Volumn 32, Issue 5, 2005, Pages 407-409

  Aydogan, Kenan ^a   Karadogan, Serap Koran ^a   Adim, Saduman Balaban ^a   Tunali, Sukran ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Ergotamine tartrate; Pityriasis rosea like eruption

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANTIHISTAMINIC AGENT; ARSENIC; BARBITURIC ACID DERIVATIVE; BCG VACCINE; BENFLUOREX; BISMUTH; CAPTOPRIL; CLONIDINE; CODEINE; CORTICOSTEROID; DIPHTHERIA TOXOID; ERGOTAMINE TARTRATE; GOLD DERIVATIVE; HEPATITIS B VACCINE; IMATINIB; ISOTRETINOIN; KETOTIFEN; LEVAMISOLE; LISINOPRIL; LITHIUM; METHOPROMAZINE; METRONIDAZOLE; NAPROXEN; OMEPRAZOLE; ORGANOMERCURY COMPOUND; PENICILLAMINE; PNEUMOCOCCUS VACCINE; SMALLPOX VACCINE; TERBINAFINE; TRIPELENNAMINE;

ADULT; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG ERUPTION; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALE; MIGRAINE; PAPULE; PITYRIASIS ROSEA; SYSTEMIC THERAPY;

EID: 21044433944     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00917.x     Document Type: Letter

References (14)

1. Parsons JM: Pityriasis rosea up-date: 1986, J Am Acad Dermatol, 15: 159-167, 1986.
2. Wilkin JK, Kirkendall WM: Pityriasis rosea-like rash from captopril, Arch Dermatol, 118: 186-187, 1982.
3. Litt JZ: Description of the 29 most common reaction patterns, in Litt JZ (ed): Drug Eruption Reference Manual 2000, Parthenon Publishing Group, London, 2000, pp 613-618.
4. Wilkinson SM, Smith AG, Davis MJ, Mattey D, Dawes PT: Pityriasis rosea and discoid eczema: Dose related reactions to treatment with gold, Ann Rheum Dis, 51: 881-884, 1992.
5. Helfman RJ, Brickman M, Fahey J: Isotretinoin dermatitis simulating acute pityriasis rosea, Cutis, 33: 297-300, 1984.
6. Maize JC, Tomecki KJ: Pityriasis rosea-like drug eruption secondary to metronidazole, Arch Dermatol, 113: 1457-1458, 1977.
7. Loche F, Thouvenin MD, Basex J: Pityriasis rosea-like eruption due to Benfluorex. Dermatology, 201: 75, 2000.
8. Meyler WJ: Side effects of ergotamine, Cephalalgia, 16: 5-10, 1996.
9. Drago F, Ranieri E, Malaguti F, et al: Human herpes virus 7 in pityriasis rosea, Lancet, 349: 1367-1368, 1997.
10. Kosuge H, Tanaka Taya K, Miyoshi H, et al: Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea, Br J Dermatol, 143: 795-798, 2000.
11. Watanabe T, Kawamura T, Jacob SE, et al: Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6, J Invest Dermatol, 119: 793-797, 2002.
12. Chuh AA, Chiu SS, Peiris JS: Human herpes virus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: A prospective case control study, Acta Derm Venereol, 81: 289-290, 2001.
13. Yildirim M, Aridogan BC, Baysal V, Inaloz HS: The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea, Int J Clin Pract, 58: 119-121, 2004.
14. Crowson AN, Magro CM: Recent advances in the pathology of cutaneous drug eruptions, Dermatol Clin, 17: 537-560, 1999.